Utah Medical Products (UTMD) Invested Capital (2010 - 2026)

Utah Medical Products has reported Invested Capital for 10 years, with the latest figure at $122.2 million in Q2 2026.

• On a quarterly basis, Invested Capital rose 4.0% year-over-year to $122.2 million in Q2 2026; TTM through Jun 2026 was $122.2 million, a 4.0% increase from a year earlier, with the FY2025 full-year figure at $119.5 million, up 1.52% from the prior year.
• Invested Capital was $122.2 million for Q2 2026 at Utah Medical Products, up from $120.6 million in the prior quarter.
• The five-year high for Invested Capital was $128.6 million in Q4 2023, with the low at $117.3 million in Q1 2025.
• Average Invested Capital over 4 years is $120.2 million, with a median of $119.0 million recorded in 2025.
• The sharpest annual moves came in 2024 and 2026: Invested Capital fell 8.47% in 2024, then rose 4.0% in 2026.
• Over 4 years, Invested Capital stood at $128.6 million in 2023, then slipped by 8.47% to $117.7 million in 2024, then grew by 1.52% to $119.5 million in 2025, then gained by 2.29% to $122.2 million in 2026.
• The last three Invested Capital figures came in at $122.2 million (Q2 2026), $120.6 million (Q1 2026), and $119.5 million (Q4 2025), per Business Quant data.